SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 92.01 |
| Enterprise Value ($M) | 90.44 |
| Book Value ($M) | 4.14 |
| Book Value / Share | 0.24 |
| Price / Book | 22.23 |
| NCAV ($M) | -13.70 |
| NCAV / Share | -0.79 |
| Price / NCAV | -6.72 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.16 |
| Return on Assets (ROA) | -1.15 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.48 |
| Current Ratio | 0.80 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.98 |
| Assets | 25.82 |
| Liabilities | 21.68 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Rakib Vivien |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,955 | 13,157 | 14.86 | |
| 779 | 17,257 | 4.51 | |
| 4,968 | 16,581 | 29.96 | |
| 3,084 | 10,655 | 28.94 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AVTE – Aerovate Therapeutics, Inc. | AXSM – Axsome Therapeutics, Inc. |
| BCAB – BioAtla, Inc. | BTMD – biote Corp. |
| CADL – Candel Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io